PINNACLE ASSOCIATES LTD - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
PINNACLE ASSOCIATES LTD ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2021$176,000
-61.0%
10,775
-59.8%
0.00%
-62.5%
Q2 2021$451,000
-54.5%
26,825
-50.6%
0.01%
-57.9%
Q1 2021$991,000
+8.3%
54,275
+7.9%
0.02%0.0%
Q4 2020$915,000
+29.6%
50,300
+27.2%
0.02%
+11.8%
Q3 2020$706,000
-60.9%
39,550
-60.7%
0.02%
-61.4%
Q2 2020$1,804,000
-24.1%
100,615
-35.7%
0.04%
-38.9%
Q1 2020$2,376,000
-25.3%
156,515
-2.9%
0.07%
+2.9%
Q4 2019$3,179,000
+16.7%
161,140
+1.7%
0.07%
+9.4%
Q3 2019$2,725,000
+4.0%
158,440
+7.0%
0.06%
+4.9%
Q2 2019$2,621,000
+0.4%
148,057
+15.5%
0.06%
+3.4%
Q1 2019$2,610,000128,1490.06%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Bartlett & Co. LLC 20,781$2960.01%
Valued Wealth Advisors LLC 231$3,5740.00%
BALDWIN BROTHERS LLC/MA 2,035$29,0390.00%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders